Featured Content

Multiple-Dose Vial Heparin Related to Severe Allergic Reactions 3/20/2008

The FDA announced that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable drug heparin, commonly used before surgery as a blood-thinning agent, due to reports of serious allergic reactions and hypotension in patients who receive high "bolus" doses of the drug.

HEPARIN

Acute Coronary Syndromes 2/20/2007

Each day, nearly 2,500 Americans die of cardiovascular disease--representing an average of one death every 35 seconds.

Advertisement